EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.
Issue link: https://digital.eyeworld.org/i/87458
EW AAO PREVIEW 47 after year." Dr. Holladay's lecture is titled "The Perfect IOL Calculation." That session takes place on Monday, Nov. 12, at approximately 11:30 a.m. Dr. Fishkind said he "highly rec- ommends" two papers: The first, "Is the error from intended refraction on the first eye in cataract surgery a predictor for error on the second eye," presented by Mark Brower, O.D., "answers questions we all think we know, but we'll get to see it scientifically here." The second paper, "Pathologic comparison of asymmetric or sulcus fixation of 3- piece IOLs with square vs. round anterior optic edges," presented by Liliana Werner, M.D., "is a subject that needs to be out there," Dr. Fishkind said. "We're continually Getting continued from page 44 A closer look Glaucoma Subspecialty Day is divided into six main topic areas: 1) Apparent Worsening, 2) Progression at Normal Pressures, 3) Narrow Angles, 4) A Need for Glaucoma Surgery (With or Without Cataract), 5) Intraoperative Challenges, and 6) Avoiding and Treating Postoperative Complications. Each topic area is a little under an hour long and fea- tures short talks from several well- known experts in the field. There will also be a midday lecture led by Mildred M.G. Oliver, M.D., Midwest Glaucoma Center, Hoffman Estates, Ill. Dr. Oliver will focus on "The Global Impact of Glaucoma: Addressing Care in Developing Countries." Dr. Oliver has done a number of medical missions in Haiti. Dr. Oliver's focus is a welcome one as managing glaucoma in devel- oping countries is often a challenge, said Dale K. Heuer, M.D., professor and chairman of ophthalmology, Medical College of Wisconsin, Milwaukee. Hot topics Hot topics this year will include glaucoma surgery and newer materi- als on normal tension glaucoma, and imaging, Dr. Alward said. Dr. Heuer believes the talks both on apparent worsening and on pro- gression at normal pressure will be of particular interest to many atten- dees. "Many of our patients seem to be progressing despite good pressure control," he said. "Better identifica- tion of progression and recognition that pressures we see in the office don't represent the full gamut of our patients' daily pressures are critical, so I'm excited to hear from our colleagues in those two segments of the program." He also believes attendees who see a good deal of angle-closure glaucoma in certain parts of the world will be particularly interested in new insights within that area. Dr. Heuer will moderate the topic area "A Need for Glaucoma Surgery (With or Without Cataract)" and give a talk titled "Advocating for Patients." Attendees of Glaucoma Subspe- cialty Day will hear updates on new technology and studies within the subspecialty, Dr. Heuer said. Glaucoma Subspecialty Day takes place on Saturday, Nov. 10, from 8 a.m. to 5:30 p.m. at McCormick Place in room E354. A complete schedule can be found at www.aao.org. EW Editors' note: The physicians have no financial interests related to this article. Contact information Alward: 319-356-3938, Wallace_alward@uiowa.edu Heuer: 414-955-7915, dheuer@mcw.edu Samuelson: 952-567-6031, twsamuelson@mneye.com Rx Only Please see adjacent page for brief prescribing information. seeing lens implants that shouldn't be in the sulcus end up there. Here's a chance to see what can happen and why it's so important to pay attention to this detail. This is a very important paper." Dr. Fishkind also suggested sur- geons not overlook the instructional courses, which are designed to help improve surgical techniques at every level of experience. "Courses are a mix—younger ophthalmologists can learn and improve their techniques, while experienced surgeons can perfect what they know," he said. Lastly, Dr. Fishkind recom- mended attending the Breakfast with the Experts sessions, where anyone can sit down with experts and "pick their brains for help or in- sight in a casual atmosphere." EW Editors' note: The physicians have no financial interests related to this article. Contact information Chang: 650-948-9123, dceye@earthlink.net Fishkind: 520-293-6740, wfishkind@earthlink.net 0.06% TRYPAN BLUE OPHTHALMIC SOLUTION VisionBlueTM is indicated for use as an aid in ophthalmic surgery by staining the anterior capsule of the lens.1 VisionBlueTM is intended to be applied directly on the anterior lens capsule, staining any portion of the capsule which comes in contact with the dye. It is recommended that after injection all excess VisionBlueTM be immediately removed from the eye by thorough irrigation of the anterior chamber. The dye does not penetrate the capsule, permitting visualization of the anterior capsule in contrast to the non stained lens cortex and inner lens material.1 VisionBlueTM is contraindicated when a non-hydrated (dry state), hydrophilic acrylic intraocular lens (IOL) is planned to be inserted into the eye because the dye may be absorbed by the IOL and stain the IOL. Adverse reactions reported following use of VisionBlueTM include D.O.R.C. International B.V. Scheijdelveweg 2 3214 VN Zuidland The Netherlands Phone: +31 181 45 80 80 Fax: +31 181 45 80 90 E-mail: sales@dorc.nl inadvertent staining of the posterior lens capsule or vitreous face. Staining of the posterior lens capsule or vitreous face is generally self limited, lasting up to one week. ORDER INFORMATION VisionBlueTM of 10 syringes of 0.5ml/box Dutch Ophthalmic USA 10 Continental Drive Bldg 1, Exeter, NH 03833, U.S.A. Phone: +1 800-75-DUTCH or +1 603-778-6929 Fax: +1 603-778-0911 E-mail: sales@dutchophthalmicusa.com Call: (800) 75-DUTCH or (603) 778-6929 E-mail: sales@dutchophthalmicusa.com 1 Melles GJR, de Waard PWT, Pameyer JH, Houdijn Beekhuis W, Trypan blue capsule staining to visualize the capsulorhexis in cataract surgery. J Cataract Refractive Surgery 1999; 25:7-9 is available in sterile packs